Cosmo Pharmaceuticals NV (C43) Stock Price & News

C43:FRA

Cosmo Pharmaceuticals NV

€87.00

-0.46%

(-0.40) 1D

May 29, 10:00:00 PM GMT+2 · EUR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for C43...

Open

€87.00

High

€87.00

Low

€87.00

Mkt. cap

1.36B

Avg. vol.

56.00

Volume

0.00

52-wk high

€141.00

52-wk low

€57.50

No. of employees

325

Open

€87.00

High

€87.00

Low

€87.00

Mkt. cap

1.36B

Avg. vol.

56.00

Volume

0.00

52-wk high

€141.00

52-wk low

€57.50

No. of employees

325

Related stocks

C44

China Resources Bldg Mtrls Tech Hldg Ltd

€0.13

+0.80%

C33

Chuan Hup Holdings Ltd

CGN New Energy Holdings Co Ltd

€0.29

+2.13%

News stories

From sources across the web

MarketBeat

29 minutes ago

Allegro MicroSystems, Inc. (NASDAQ:ALGM) Given Average Recommendation of "Moderate Buy" by Analysts

AOL.com

1 hour ago

Americans Have Never Been This Pessimistic. The Stock Market Doesn't Agree, and History Says the Market Wins.

MarketBeat

29 minutes ago

Applied Optoelectronics, Inc. (NASDAQ:AAOI) Receives Average Rating of "Hold" from Analysts

CNBC

18 hours ago

Berkshire trails red-hot S&P 500 by biggest margin so far this year

About Cosmo Pharmaceuticals NV

CEO-

Employees325

Founded1997

Headquarters-

SectorPharmaceutical industry

Websitecosmohealthconfidence.com

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	25.86M	25.86M	26.23M	26.23M
Cost of goods sold	12.79M	12.79M	14.02M	14.02M
Cost of revenue	12.79M	12.79M	14.02M	14.02M
Research and development expenses	9.00M	9.00M	8.09M	8.09M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	7.13M	7.13M	6.27M	6.27M
Operating expense	13.78M	13.78M	14.97M	14.97M
Total operating expenses	26.57M	26.57M	28.99M	28.99M
Operating income	-705.50K	-705.50K	-2.76M	-2.76M
Other non operating income	-17.50K	-17.50K	-13.00K	-13.00K
EBT including unusual items	-335.00K	-335.00K	-124.00K	-124.00K
EBT excluding unusual items	-1.55M	-1.55M	-916.00K	-916.00K
Income tax expense	680.00K	680.00K	606.00K	606.00K
Effective tax rate	-202.99%	-202.99%	-488.71%	-488.71%
Other operating expenses	-2.35M	-2.35M	611.00K	611.00K
Net income	-1.00M	-1.00M	-801.00K	-801.00K
Net profit margin	-3.88%	-3.88%	-3.05%	-3.05%
Earnings per share	-	-	-	-
Interest and investment income	360.50K	360.50K	2.02M	2.02M
Interest expense	-31.50K	-31.50K	-28.50K	-28.50K
Net interest expenses	329.00K	329.00K	1.99M	1.99M
Depreciation and amortization charges	-	-	-	-
EBITDA	2.43M	2.43M	104.50K	104.50K
Gain or loss from assets sale	-	-	13.00K	13.00K

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research